GLP-1s may improve outcomes in patients with PAD, diabetes

Дата публикации: 08-07-2026 14:48:04

GLP-1s may prevent adverse outcomes in patients with peripheral artery disease and diabetes, according to data published in the Journal of the American Heart Association.Researchers reported that GLP-1 receptor agonist use among patients with PAD and diabetes was associated with lower risk for mortality, hospitalization, revascularization and amputation compared with those prescribed metformin.“Obesity and PAD, including chronic limb-threatening ischemia, are linked to increased inflammation, poor blood vessel function, insulin resistance, oxidative stress and faster hardening of the

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	GLP-1 Medications May Improve Health in People With PAD and Diabetes	0	9.88	18-08-2026
2	GLP-1s may lower risk for death, heart events among people with hidradenitis suppurativa	5	7	08-07-2026
3	GLP-1s for diabetes may increase risk for psoriatic disease	0	8.45	28-07-2026
4	GLP-1 treatment linked to lower risk of hospitalization and death in older adults with fatty liver disease	0	6.87	13-10-2026
5	Do GLP-1s belong in dermatology? Evidence suggests a growing role	0	11.72	12-08-2026
6	New GLP-1 diabetes pill delivers major weight loss and blood sugar control	0	6.91	15-06-2026
7	Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity	7	8	31-07-2025
8	Different GLP-1 therapies could be tailored to patients' individual metabolic needs	0	7.25	27-07-2026
9	Препараты для похудения связали со снижением риска переломов	0	9.85	06-08-2026
10	SGLT2 and GLP-1 medications unlock new potential in CKM care	2	6	09-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: www.healio.com.